Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 23
Filtrar
1.
Pharm Biol ; 52(1): 105-10, 2014 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-24102122

RESUMEN

CONTEXT: Hypericum caprifoliatum Cham & Schlecht (Guttiferae) extracts have a potential antidepressant-like effect in rodents. However, the molecular mechanisms by which these extracts exert this effect remain unclear. OBJECTIVE: This study evaluated the effect of HC1, a fraction obtained from H. caprifoliatum enriched in phloroglucinol derivatives, on the Na⁺, K⁺ ATPase activity in mouse brain and verified the influence of veratrine on the effect of HC1 in the forced swimming test (FST). MATERIALS AND METHODS: Veratrine (0.06 mg/kg) and HC1 (360 mg/kg) were given alone or combined i.p. 60 and p.o. 30 min, respectively, before FST. The effect of single and repeated administration (once a day for 3 consecutive days) of HC1 (360 mg/kg) on Na⁺, K⁺ ATPase activity was evaluated ex vivo in the cerebral cortex and hippocampus of mice subjected or not to FST. RESULTS: HC1 reduced the immobility time (103.15 ± 18.67 s), when compared to the control group (183.6 ± 9.51 s). This effect was prevented by veratrine (151.75 ± 22.19 s). Mice repeatedly treated with HC1 presented a significant increase in Na⁺, K⁺ ATPase activity, both in cerebral cortex (46 ± 2.41 nmol Pi/min·mg protein) and hippocampus (49.83 ± 2.31 nmol Pi/min·mg protein), in relation to the respective controls (30 ± 2.66 and 29.83 ± 2.31 nmol Pi/min·mg protein respectively). DISCUSSION AND CONCLUSION: The HC1 antidepressant-like effect on FST might be related to its capacity to inhibit Na⁺ influx. HC1 increases hippocampal and cortical Na⁺, K⁺ ATPase activities possibly through long-term regulatory mechanisms.


Asunto(s)
Antidepresivos/farmacología , Depresión/tratamiento farmacológico , Floroglucinol/farmacología , Extractos Vegetales/farmacología , Animales , Antidepresivos/administración & dosificación , Antidepresivos/aislamiento & purificación , Corteza Cerebral/efectos de los fármacos , Corteza Cerebral/metabolismo , Modelos Animales de Enfermedad , Hipocampo/efectos de los fármacos , Hipocampo/metabolismo , Hypericum , Masculino , Ratones , Floroglucinol/administración & dosificación , Floroglucinol/aislamiento & purificación , Extractos Vegetales/administración & dosificación , Sodio/metabolismo , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Natación , Veratrina/administración & dosificación , Veratrina/farmacología
2.
Metab Brain Dis ; 27(4): 605-12, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-22968482

RESUMEN

The use of psychostimulant methylphenidate has increased in recent years for the treatment of attention-deficit hyperactivity disorder in children and adolescents. However, the behavioral and neurochemical changes promoted by its use are not yet fully understood, particularly when used for a prolonged period during stages of brain development. Thus, the aim of this study was to determine some parameters of oxidative stress in encephalic structures of juvenile rats subjected to chronic methylphenidate treatment. Wistar rats received intraperitoneal injections of methylphenidate (2.0 mg/kg) once a day, from the 15th to the 45th day of age or an equivalent volume of 0.9% saline solution (controls). Two hours after the last injection, animals were euthanized and the encephalic structures obtained for determination of oxidative stress parameters. Results showed that methylphenidate administration increased the activities of superoxide dismutase and catalase, but did not alter the levels of reactive species, thiobarbituric acid reactive substances levels and sulfhydryl group in cerebellum of rats. In striatum and hippocampus, the methylphenidate-treated rats presented a decrease in the levels of reactive species and thiobarbituric acid reactive substances, but did not present changes in the sulfhydryl groups levels. In prefrontal cortex, methylphenidate promoted an increase in reactive species formation, SOD/CAT ratio, and increased the lipid peroxidation and protein damage. These findings suggest that the encephalic structures respond differently to methylphenidate treatment, at least, when administered chronically to young rats. Notably, the prefrontal cortex of juvenile rats showed greater sensitivity to oxidative effects promoted by methylphenidate in relation to other encephalic structures analyzed.


Asunto(s)
Estimulantes del Sistema Nervioso Central/toxicidad , Metilfenidato/toxicidad , Corteza Prefrontal/metabolismo , Animales , Antioxidantes/metabolismo , Catalasa/metabolismo , Cerebelo/efectos de los fármacos , Cerebelo/metabolismo , Fluoresceínas , Glutatión Peroxidasa/metabolismo , Hipocampo/efectos de los fármacos , Hipocampo/metabolismo , Inyecciones Intraperitoneales , Neostriado/efectos de los fármacos , Neostriado/metabolismo , Óxido Nítrico/metabolismo , Estrés Oxidativo/fisiología , Corteza Prefrontal/patología , Ratas , Ratas Wistar , Especies de Nitrógeno Reactivo/metabolismo , Compuestos de Sulfhidrilo/metabolismo , Superóxido Dismutasa/metabolismo , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo
3.
Neurochem Res ; 36(12): 2373-80, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-21822921

RESUMEN

Learning and memory deficits occur in depression and other stress related disorders. Although the pathogenesis of cognitive impairment after stress has not been fully elucidated, factors such as oxidative stress and neurotrophins are thought to play possible roles. Here we investigated the effect of treatment with vitamin E (40 mg/kg) and vitamin C (100 mg/kg) on the effects elicited by chronic variable stress on rat performance in Morris water maze. Brain-derived neurotrophic factor (BDNF) immunocontent was also evaluated in hippocampus of rats. Sixty-day old Wistar rats were submitted to different stressors for 40 days (stressed group). Half of stressed group received administration of vitamins once a day, during the period of stress. Chronically stressed rats presented a marked decrease in reference memory in the water maze task as well as a reduced efficiency to find the platform in the working memory task. Rats treated with vitamins E and C had part of the above effects prevented, suggesting the participation of oxidative stress in such effects. The BDNF levels were not altered in hippocampus of stressed group when compared to controls. Our findings lend support to a novel therapeutic strategy, associated with these vitamins, to the cognitive dysfunction observed in depression and other stress related diseases.


Asunto(s)
Antioxidantes/uso terapéutico , Ácido Ascórbico/uso terapéutico , Trastornos de la Memoria/tratamiento farmacológico , Estrés Psicológico/psicología , Vitamina E/uso terapéutico , Animales , Factor Neurotrófico Derivado del Encéfalo/metabolismo , Trastornos del Conocimiento/tratamiento farmacológico , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Ratas , Ratas Wistar
4.
Neurochem Res ; 36(3): 487-93, 2011 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-21184279

RESUMEN

In the present study we investigated the effect of chronic variable stress (CVS) on some parameters of the immune system, including levels of cytokines [interleukin 1ß (IL-1 ß), interleukin 6 (IL-6), tumor necrosis factor α (TNF- α)] and chemokine CCL2 (MCP-1) in the hippocampus of rats. Acetylcholinesterase activity was also evaluated. Sixty-day old Wistar rats were submitted to different mild stressors for 40 days. After the last stress section, the cytokines and MCP-1 were determined by immunoassay and acetylcholinesterase activity by colorimetric method. Results showed that chronic stress significantly increased the levels of IL-1ß, IL-6 and TNF-α, but did not alter the levels of MCP-1. In addition, acetylcholinesterase activity was increased in the hippocampus of rats subjected to CVS. These findings suggest that inflammation and cholinergic dysfunction may be, at least in part, important contributors to the neurological dysfunction observed in some depressed patients.


Asunto(s)
Acetilcolinesterasa/metabolismo , Quimiocina CCL2/inmunología , Citocinas/inmunología , Inflamación/inmunología , Estrés Psicológico/inmunología , Glándulas Suprarrenales/anatomía & histología , Animales , Peso Corporal , Hipocampo/metabolismo , Masculino , Tamaño de los Órganos , Ratas , Ratas Wistar
5.
Metab Brain Dis ; 26(1): 61-7, 2011 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-21287399

RESUMEN

In the present study we investigate the effect of homocysteine on glutamate uptake, Na+,K+-ATPase, enzymatic antioxidant defenses, as well as reactive species levels in hippocampus of rats. The influence of vitamin C, a classic antioxidant, on the effects elicited by homocysteine was also tested. Results showed that chronic hyperhomocysteinemia decreased glutamate uptake and the activities of Na+,K+-ATPase, catalase and superoxide dismutase in hippocampus of rats. Reactive species levels were increased by chronic homocysteine administration. Concomitant administration of vitamin C significantly prevented these alterations caused by homocysteine. According to our results, it seems possible to suggest that the reduction in glutamate uptake and Na+,K+-ATPase activity may be mediated by oxidative stress, since vitamin C prevented these effects. We suggest that the administration of antioxidants should be considered as an adjuvant therapy to specific diet in homocystinuria.


Asunto(s)
Ácido Ascórbico/farmacología , Ácido Glutámico/metabolismo , Homocisteína/administración & dosificación , Estrés Oxidativo/efectos de los fármacos , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Animales , Antioxidantes/farmacología , Catalasa/metabolismo , Hipocampo/efectos de los fármacos , Hipocampo/metabolismo , Homocistinuria/terapia , Hiperhomocisteinemia/metabolismo , Ratas , Ratas Wistar , Especies Reactivas de Oxígeno/metabolismo , Superóxido Dismutasa/metabolismo
6.
Neurochem Res ; 35(11): 1787-95, 2010 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-20717721

RESUMEN

In this study, we examined the effects of two chronic stress regimens upon anxiety-like behavior, Na(+), K(+)-ATPase activity and immunocontent, and oxidative stress parameters (antioxidant enzymes and reactive oxygen species production) in the amygdala. Male rats were subjected to chronic unpredictable and to chronic restraint stress for 40 days. Subsequently, anxiety-like behavior was examined. Both stressed groups presented increased anxiety-like behavior. Reduced amygdalal Na(+), K(+)-ATPase activity in the synaptic plasma membranes was also observed, without alterations in the amygdala immunocontent. In addition, when analyzing oxidative stress parameters, only superoxide dismutase activity was decreased in the amygdala of animals subjected to unpredictable stress. We conclude that both models of chronic stress lead to anxiety-like behavior and decreased amygdalal Na(+), K(+)-ATPase activity, which appears not to be related to oxidative imbalance. The relationship between this decreased activity and anxiety-like behavior remains to be studied.


Asunto(s)
Amígdala del Cerebelo/enzimología , Conducta Animal/fisiología , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Estrés Psicológico/enzimología , Animales , Ansiedad/etiología , Masculino , Estrés Oxidativo/efectos de los fármacos , Ratas , Ratas Wistar
7.
J Neural Transm (Vienna) ; 117(9): 1067-76, 2010 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20686907

RESUMEN

Depressive disorders, including major depression, are serious and disabling, whose mechanisms are not clearly understood. Since life stressors contribute in some fashion to depression, chronic variable stress (CVS) has been used as an animal model of depression. In the present study we evaluated some parameters of oxidative stress [thiobarbituric acid reactive substances (TBARS), catalase (CAT), superoxide dismutase (SOD) and glutathione peroxidase (GPx)], and inflammatory markers (interleukin 6, C reactive protein, tumor necrosis factor-alpha and nitrites), as well as the activity of butyrylcholinesterase in blood of rats subjected to chronic stress. Homocysteine and folate levels also were measured. Stressed animals were submitted to different mild stressors for 40 days. After CVS, a reduction in weight gain was observed in the stressed group, as well as an increase in immobility time in the forced swimming test as compared with controls. Stressed animals presented a significant increase on TBARS and SOD/CAT ratio, but stress did not alter GPx activity and any inflammatory parameters studied. CVS caused a significant inhibition on serum butyrylcholinesterase activity. Stressed rats had higher plasmatic levels of homocysteine without differences in folate levels. Although it is difficult to extrapolate our findings to the human condition, the alterations observed in this work may be useful to help to understand, at least in part, the pathophysiology of depressive disorders.


Asunto(s)
Butirilcolinesterasa/metabolismo , Depresión/metabolismo , Estrés Oxidativo/fisiología , Estrés Fisiológico/fisiología , Estrés Psicológico/metabolismo , Animales , Proteína C-Reactiva/metabolismo , Catalasa/sangre , Glutatión Peroxidasa/sangre , Inmunoensayo , Interleucina-6/sangre , Masculino , Ratas , Ratas Wistar , Superóxido Dismutasa/sangre , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo , Factor de Necrosis Tumoral alfa/sangre
8.
Metab Brain Dis ; 25(2): 169-76, 2010 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-20505986

RESUMEN

Since chronic stress has been used widely for studying clinical depression and that brain energy metabolism and oxidative stress might be involved in the pathophysiology of this illness, the objective of this study was investigate the activities of pyruvate kinase, complex II and IV (cytocrome c oxidase) in hippocampus and prefrontal cortex of rats submitted to chronic variable stress. We also evaluated if vitamins E and C administration could prevent such effects. During 40 days adult rats from the stressed group were subjected to one stressor per day, at a different time each day, in order to minimize predictability. The stressed group had gained less weight while its immobilization time in the forced swimming test was greater than that of the control group. Results showed that stressed group presented an inhibition in the activities of complex II and cytochrome c oxidase in prefrontal cortex, while in hippocampus just complex IV was inhibited. Pyruvate kinase activity was not altered in stressed group when compared to control. Vitamins E and C administration prevented the alterations on respiratory chain caused by stress. These data suggest that the impairment of energy metabolism and oxidative stress could be related with the pathogenic pathways in stress related disorders.


Asunto(s)
Antioxidantes/uso terapéutico , Encefalopatías Metabólicas/tratamiento farmacológico , Metabolismo Energético/efectos de los fármacos , Hipocampo/metabolismo , Estrés Oxidativo/efectos de los fármacos , Corteza Prefrontal/metabolismo , Estrés Psicológico/metabolismo , Estrés Psicológico/prevención & control , Animales , Antioxidantes/farmacología , Ácido Ascórbico/farmacología , Ácido Ascórbico/uso terapéutico , Encefalopatías Metabólicas/etiología , Enfermedad Crónica , Modelos Animales de Enfermedad , Transporte de Electrón/efectos de los fármacos , Transporte de Electrón/fisiología , Complejo IV de Transporte de Electrones/efectos de los fármacos , Complejo IV de Transporte de Electrones/metabolismo , Metabolismo Energético/fisiología , Hipocampo/efectos de los fármacos , Hipocampo/enzimología , Estrés Oxidativo/fisiología , Corteza Prefrontal/efectos de los fármacos , Corteza Prefrontal/enzimología , Piruvato Quinasa/metabolismo , Ratas , Ratas Wistar , Estrés Psicológico/complicaciones , Vitamina E/farmacología , Vitamina E/uso terapéutico
9.
Metab Brain Dis ; 25(2): 161-8, 2010 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-20437088

RESUMEN

In the present study we investigated the effect of acute hyperprolinemia on some parameters of energy metabolism, including the activities of succinate dehydrogenase and cytocrome c oxidase and (14)CO(2) production from glucose and acetate in cerebral cortex of young rats. Lipid peroxidation determined by the levels of thiobarbituric acid-reactive substances, as well as the influence of the antioxidants alpha-tocopherol plus ascorbic acid on the effects elicited by Pro on enzyme activities and on the lipid peroxidation were also evaluated. Wistar rats of 12 and 29 days of life received one subcutaneous injection of saline or proline (12.8 or 18.2 micromol/g body weight, respectively) and were sacrificed 1 h later. In another set of experiments, 5- and 22-day-old rats were pretreated for a week with daily intraperitoneal administration of alpha-tocopherol (40 mg/kg) plus ascorbic acid (100 mg/kg) or saline. Twelve hours after the last injection, rats received one injection of proline or saline and were sacrificed 1 h later. Results showed that acute administration of proline significantly reduced cytochrome c oxidase activity and increased succinate dehydrogenase activity and (14)CO(2) production in cerebral cortex, suggesting that Pro might disrupt energy metabolism in brain of young rats. In addition, proline administration increased the thiobarbituric acid-reactive substances levels, which were prevented by antioxidants. These findings suggest that mitochondrial dysfunction and oxidative stress may be important contributors to the neurological dysfunction observed in some hyperprolinemic patients and that treatment with antioxidants may be beneficial in this pathology.


Asunto(s)
Encefalopatías Metabólicas/metabolismo , Corteza Cerebral/efectos de los fármacos , Corteza Cerebral/metabolismo , Metabolismo Energético/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Prolina/efectos adversos , Factores de Edad , Envejecimiento/metabolismo , Animales , Antioxidantes/farmacología , Antioxidantes/uso terapéutico , Ácido Ascórbico/farmacología , Ácido Ascórbico/uso terapéutico , Encefalopatías Metabólicas/inducido químicamente , Corteza Cerebral/crecimiento & desarrollo , Modelos Animales de Enfermedad , Sinergismo Farmacológico , Metabolismo Energético/fisiología , Peroxidación de Lípido/efectos de los fármacos , Peroxidación de Lípido/fisiología , Estrés Oxidativo/fisiología , Prolina/metabolismo , Ratas , Ratas Wistar , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo , alfa-Tocoferol/farmacología , alfa-Tocoferol/uso terapéutico
10.
Int J Dev Neurosci ; 24(4): 285-91, 2006 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-16542814

RESUMEN

In the present study we evaluate the effects of homocysteine on cellular damage using hippocampal slices from Wistar rats exposed to oxygen and glucose deprivation (OGD, followed by reoxygenation), an in vitro model of hypoxic-ischemic events. For chronic treatment, we induced elevated levels of homocysteine in blood (500 microM), comparable to those of human homocystinuria, and in brain (60 nmol/g wet tissue) of young rats by subcutaneous injections of homocysteine (0.3-0.6 micromol/g of body weight), twice a day with 8 h intervals, from the 6 th to the 28 th postpartum day and controls received saline. Rats were sacrificed 1, 3 or 12 h after the last injection. For acute treatment, 29-day-old rats received one single injection of homocysteine (0.6 micromol homocysteine/g body weight) or saline and were sacrificed 1h later. In another set of experiments rats were pretreated with Vitamins E (40 mg/kg) and C (100 mg/kg) or folic acid (5 mg/kg) during 1 week; 12 h after the last administration they received a single injection of homocysteine or saline and were sacrificed 1 h later. Results showed that both chronic (1 h after homocysteine administration) and acute hyperhomocysteinemia increased the cellular damage measured by LDH released to de incubation medium, suggesting an increase of tissue damage caused by OGD. Pretreatment with folic acid completely prevented the damage caused by acute hyperhomocysteinemia, whereas Vitamin E just partially prevented such effect. These findings may be relevant to explain, at least in part, the higher susceptibility of hyperhomocysteinemic patients to be susceptible to ischemic events and point to a possible preventive treatment.


Asunto(s)
Ácido Fólico/uso terapéutico , Glucosa/deficiencia , Hiperhomocisteinemia/complicaciones , Hipoxia-Isquemia Encefálica/prevención & control , Hipoxia , Complejo Vitamínico B/uso terapéutico , Análisis de Varianza , Animales , Modelos Animales de Enfermedad , Esquema de Medicación , Interacciones Farmacológicas , Homocisteína/administración & dosificación , Homocisteína/efectos adversos , Hiperhomocisteinemia/inducido químicamente , Técnicas In Vitro , Lactato Deshidrogenasas/metabolismo , Masculino , Ratas , Ratas Wistar , Vitamina A/uso terapéutico
11.
Neurochem Int ; 43(6): 597-602, 2003 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-12820989

RESUMEN

Homocystinuria is an inborn error of metabolism caused by severe deficiency of cystathionine beta-synthase activity. It is biochemically characterized by tissue accumulation of homocysteine (Hcy) and methionine (Met). Homocystinuric patients present a variable degree of neurological dysfunction whose pathophysiology is poorly understood. In the present study, we investigated the in vitro effect of Hcy and Met on some parameters of energy metabolism in hippocampus of rats. CO(2) production from [U-14C] acetate, glucose uptake and lactate release were assessed by incubating hippocampus prisms from 28-day-old rats in Krebs-Ringer bicarbonate buffer, pH 7.4, in the absence (controls) or presence of Hcy (10-500 microM) or Met (0.2-2.0mM). Hcy and Met decreased CO(2) production in a dose-dependent manner and increased lactate release. In contrast, glucose uptake was not altered by the metabolites. The effect of Hcy and Met on cytochrome c oxidase activity was also studied. It was observed that Met did not alter this enzyme activity, in contrast with Hcy, which significantly inhibited cytochrome c oxidase activity. It is suggested that impairment of brain energy metabolism caused by the metabolites accumulating in homocystinuria may be related to the neurological symptoms present in homocystinuric patients.


Asunto(s)
Encéfalo/metabolismo , Metabolismo Energético , Homocistinuria/metabolismo , Animales , Encéfalo/efectos de los fármacos , Dióxido de Carbono/metabolismo , Modelos Animales de Enfermedad , Complejo IV de Transporte de Electrones/metabolismo , Metabolismo Energético/efectos de los fármacos , Glucosa/metabolismo , Hipocampo/metabolismo , Homocisteína/farmacología , Metionina/farmacología , Ratas , Ratas Wistar
12.
Brain Res ; 983(1-2): 58-63, 2003 Sep 05.
Artículo en Inglés | MEDLINE | ID: mdl-12914966

RESUMEN

Hyperargininemia is an inherited metabolic disease biochemically characterized by tissue accumulation of arginine. Mental retardation and other neurological features are common symptoms in hyperargininemic patients. Considering that the underlying mechanisms of brain damage in this disease are poorly established, in this work we investigated the effect of arginine administration to adult Wistar rats on some parameters of energy metabolism (CO(2) production, glucose uptake, lactate release and the activities of succinate dehydrogenase, complexes II and IV of the respiratory chain) in rat hippocampus. The action of L-NAME, an inhibitor of oxide nitric oxide synthase, on the effects produced by arginine was also tested. Sixty-day-old rats were treated with a single intraperitoneal injection of saline (group I, control), arginine (0.8 g/kg) (group II) or arginine (0.8 g/kg) plus L-NAME (2 mg/kg) (group III) and were killed 1 h later. Results showed that arginine administration significantly increased lactate release and diminished CO(2) production, glucose uptake, succinate dehydrogenase and complex II activities. In contrast, complex IV (cytochrome c oxidase) activity was not changed by this amino acid. Furthermore, simultaneous injection of L-NAME prevented some of these effects, except CO(2) production and lactate release. The present data indicate that in vivo arginine administration impairs some parameters of energy metabolism in hippocampus of rats probably through NO formation.


Asunto(s)
Arginina/farmacología , Metabolismo Energético/efectos de los fármacos , Hipocampo/metabolismo , Animales , Dióxido de Carbono/metabolismo , Depresión Química , Transporte de Electrón/efectos de los fármacos , Complejo IV de Transporte de Electrones/metabolismo , Inhibidores Enzimáticos/farmacología , Glucosa/metabolismo , Hipocampo/efectos de los fármacos , Indicadores y Reactivos , Ácido Láctico/metabolismo , NG-Nitroarginina Metil Éster/farmacología , Proteínas del Tejido Nervioso/metabolismo , Óxido Nítrico/fisiología , Óxido Nítrico Sintasa/antagonistas & inhibidores , Óxido Nítrico Sintasa de Tipo I , Ratas , Ratas Wistar , Succinato Deshidrogenasa/metabolismo
13.
Int J Dev Neurosci ; 20(2): 77-81, 2002 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-12034138

RESUMEN

In the present work, we investigated the kinetics of the inhibition of Na(+), K(+)-ATPase activity caused by homocysteine (Hcy) in rat hippocampus. We also studied the interaction between Hcy and phenylalanine (Phe) and the kinetics of alanine (Ala) reversal of the inhibition of Na(+), K(+)-ATPase caused by Hcy. The apparent K(m) and V(max) of Na(+), K(+)-ATPase for ATP as substrate were 0.55mM and 2.0nmol Pi released per min per mg of protein, respectively. K(i) value was approximately 0.1mM, and the inhibition was of the non-competitive type. The results also showed a competition between Hcy and Phe. Ala per se did not alter this enzyme, but prevented the inhibitory effect caused by Hcy, suggesting a common binding site for these substances. It is proposed that the inhibition of Na(+), K(+)-ATPase by Hcy may be one of the mechanisms related to the neuronal dysfunction observed in human homocystinuria.


Asunto(s)
Hipocampo/metabolismo , Homocisteína/metabolismo , ATPasa Intercambiadora de Sodio-Potasio/antagonistas & inhibidores , Alanina/metabolismo , Animales , Cinética , Fenilalanina/metabolismo , Ratas , Ratas Wistar
14.
Int J Dev Neurosci ; 22(1): 11-7, 2004 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-15013074

RESUMEN

In the present study, we investigated the in vitro effect of hypoxanthine, xanthine and uric acid, metabolites accumulating in tissue of patients with Lesch-Nyhan disease, on Na(+), K(+)-ATPase activity in striatum of neonate rats. Results showed that all compounds significantly inhibited Na(+), K(+)-ATPase activity. We also studied the kinetics of the inhibition of Na(+), K(+)-ATPase activity caused by hypoxanthine. The apparent K(m) and V(max) of Na(+), K(+)-ATPase activity for ATP as the substrate and hypoxanthine as the inhibitor were 0.97 mM and 0.69 nmol inorganic phosphate (Pi) released per min per mg of protein, respectively. K(i)-value was 1.9 microM, and the inhibition was of the non-competitive type. We also observed that the inhibitory effects of hypoxanthine, xanthine and uric acid probably occur through the same mechanism, suggesting a common binding site for these oxypurines on Na(+), K(+)-ATPase. Therefore, it is conceivable that inhibition of brain Na(+), K(+)-ATPase activity may be involved at least in part in the neuronal dysfunction characteristic of patients with Lesch-Nyhan disease.


Asunto(s)
Cuerpo Estriado/efectos de los fármacos , Síndrome de Lesch-Nyhan/metabolismo , ATPasa Intercambiadora de Sodio-Potasio/antagonistas & inhibidores , Membranas Sinápticas/efectos de los fármacos , Análisis de Varianza , Animales , Animales Recién Nacidos , Cuerpo Estriado/enzimología , Relación Dosis-Respuesta a Droga , Interacciones Farmacológicas , Humanos , Hipoxantina/farmacología , Técnicas In Vitro , Cinética , Modelos Lineales , Ratas , Ácido Úrico/farmacología , Xantina/farmacología
15.
Physiol Behav ; 80(4): 475-9, 2004 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-14741232

RESUMEN

Compelling evidence has indicated the involvement of Na(+),K(+)-ATPase in the mechanisms of synaptic plasticity. In the present study, we investigated the effect of inhibitory avoidance training on Na(+),K(+)-ATPase activity, at different times after training, in the rat hippocampus. Male adult Wistar rats were trained in a step-down inhibitory avoidance task and compared to those submitted to isolated footshock (0.4 mA) or placed directly onto the platform. Na(+),K(+)-ATPase activity decreased, by 60%, in hippocampus of rats sacrificed immediately after the isolated footshock, as well as immediately (0 min) and 6 h after training; this effect was not present 24 h after training. We also verified that enzyme activity was not altered in rats killed after just being on the platform. These findings suggest that Na(+),K(+)-ATPase activity may be involved in the memory consolidation of step-down inhibitory avoidance in the hippocampus.


Asunto(s)
Reacción de Prevención/fisiología , Hipocampo/enzimología , Potenciación a Largo Plazo/fisiología , Memoria/fisiología , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Animales , Masculino , Plasticidad Neuronal/fisiología , Práctica Psicológica , Ratas , Ratas Wistar
16.
Toxicol In Vitro ; 28(4): 544-51, 2014 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-24412540

RESUMEN

Glutamate is the major excitatory neurotransmitter in the brain and over-stimulation of the glutamate receptors, NMDA, AMPA and kainate (KA), may cause neuronal death in epilepsy, seizures and neurodegenerative diseases. Mitochondria have critical cellular functions that influence neuronal excitability, such as regulation of Ca(2+) homeostasis and ATP production to maintain Na(+)K(+)-ATPase in the central nervous system (CNS). However, mitochondria are also the primary site of reactive oxygen species (ROS) production, and oxidative stress can induce cellular damage. Resveratrol, a polyphenol found in grapes and wines, presents antioxidant and neuroprotective effects on brain pathologies. This study sought to determine the neuroprotective effect of resveratrol against glutamate toxicity in acute hippocampal slices, using specific inhibitors of glutamate channels, and to investigate the targets of glutamate excitotoxicity, such as mitochondrial membrane potential (ΔΨ(m)), Na(+)K(+)-ATPase and glutamine synthetase (GS) activity. Resveratrol decreases intracellular ROS production, most likely by mechanisms involving NMDA, AMPA/KA, intracellular Ca(2+) and the heme oxygenase 1 (HO1) pathway, and prevents mitochondrial dysfunction and impairments in Na(+)K(+)-ATPase and GS activity after glutamate activation. Taken together, these results show that resveratrol may exhibit an important neuroprotective mechanism against neuropsychiatric disorders, focusing on mitochondrial bioenergetics and oxidative stress, as well as inhibitory effects on ionic channels.


Asunto(s)
Hipocampo/efectos de los fármacos , Hipocampo/metabolismo , Estrés Oxidativo/efectos de los fármacos , Receptores AMPA/metabolismo , Receptores de Ácido Kaínico/metabolismo , Receptores de N-Metil-D-Aspartato/metabolismo , Estilbenos/farmacología , Animales , Antioxidantes/administración & dosificación , Antioxidantes/farmacología , Astrocitos/efectos de los fármacos , Astrocitos/enzimología , Regulación de la Expresión Génica/efectos de los fármacos , Regulación de la Expresión Génica/fisiología , Glutamato-Amoníaco Ligasa/metabolismo , Ácido Glutámico/farmacología , Peroxidación de Lípido , Masculino , Mitocondrias/efectos de los fármacos , Mitofagia/efectos de los fármacos , Fármacos Neuroprotectores/administración & dosificación , Fármacos Neuroprotectores/farmacología , Ratas , Ratas Wistar , Especies Reactivas de Oxígeno , Receptores AMPA/genética , Receptores de Ácido Kaínico/genética , Receptores de N-Metil-D-Aspartato/genética , Resveratrol , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Estilbenos/administración & dosificación
17.
Int J Dev Neurosci ; 28(1): 21-30, 2010 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-19822200

RESUMEN

The aim of the present work was to investigate the actions of a chemically induced chronic hyperhomocysteinemia model on intermediate filaments (IFs) of cortical and hippocampal neural cells and explore signaling mechanisms underlying such effects. Results showed that in hyperhomocysteinemic rats the expression of neural IF subunits was affected. In cerebral cortex, glial fibrillary acidic protein (GFAP) expression was donwregulated while in hippocampus high and middle molecular weight neurofilament subunits (NF-H and NF-M, respectively) were up-regulated. Otherwise, the immunocontent of IF proteins was unaltered in cerebral cortex while in hippocampus the immunocontent of cytoskeletal-associated low molecular weight neurofilament (NF-L) and NF-H subunits suggested a stoichiometric ratio consistent with a decreased amount of core filaments enriched in lateral projections. These effects were not accompanied by an alteration in IF phosphorylation. In vitro results showed that 500muM Hcy-induced protein phosphatases 1-, 2A- and 2B-mediated hypophosphorylation of NF subunits and GFAP in hippocampal slices of 17-day-old rats without affecting the cerebral cortex, showing a window of vulnerability of cytoskeleton in developing hippocampus. Ionotropic and metabotropic glutamate receptors were involved in this action, as well as Ca(2+) release from intracellular stores through ryanodine receptors. We propose that the mechanisms observed in the hippocampus of 17-day-old rats could support the neural damage observed in these animals.


Asunto(s)
Encéfalo/crecimiento & desarrollo , Encéfalo/metabolismo , Calcio/metabolismo , Ácido Glutámico/metabolismo , Hiperhomocisteinemia/metabolismo , Filamentos Intermedios/metabolismo , Envejecimiento , Animales , Corteza Cerebral/crecimiento & desarrollo , Corteza Cerebral/metabolismo , Enfermedad Crónica , Modelos Animales de Enfermedad , Hipocampo/crecimiento & desarrollo , Hipocampo/metabolismo , Técnicas In Vitro , Proteínas de Filamentos Intermediarios/metabolismo , Fosforilación , Ratas , Ratas Wistar , Receptores de Glutamato/metabolismo , Receptores de Glutamato Metabotrópico/metabolismo , Canal Liberador de Calcio Receptor de Rianodina/metabolismo
18.
Metab Brain Dis ; 21(4): 273-8, 2006 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17103328

RESUMEN

Homocystinuria is an inherited metabolic disorder caused by severe deficiency of cystationine beta-synthase activity, resulting in the tissue accumulation of homocysteine (Hcy). Affected patients usually present many signs and symptoms such as seizures, mental retardation, atherosclerosis and stroke. The aim of this study is to evaluate in vivo and in vitro effects of Hcy using hippocampal slices from Wistar rats exposed to oxygen and glucose deprivation (OGD), followed by reoxygenation, an in vitro model of hypoxic-ischemic events. Neural cell injury was quantified by the measurement of lactate dehydrogenase (LDH) released from damaged cells into the extracellular fluid. The results showed that both in vivo and in vitro Hcy increased the LDH released to de incubation medium, suggesting an increase of tissue damage caused by OGD. This fact can be related with the high incidence of stroke in homocystinuric patients.


Asunto(s)
Isquemia Encefálica/metabolismo , Hipocampo/metabolismo , Homocisteína/farmacología , Homocistinuria/metabolismo , Degeneración Nerviosa/metabolismo , Animales , Isquemia Encefálica/patología , Muerte Celular , Glucosa/farmacología , Hipocampo/patología , Homocisteína/sangre , Homocistinuria/patología , L-Lactato Deshidrogenasa/metabolismo , Masculino , Degeneración Nerviosa/patología , Técnicas de Cultivo de Órganos , Oxígeno/farmacología , Ratas , Ratas Wistar , Daño por Reperfusión/metabolismo , Daño por Reperfusión/patología
19.
Cell Mol Neurobiol ; 26(2): 177-89, 2006 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-16619133

RESUMEN

1. We have previously demonstrated that arginine administration induces oxidative stress and compromises energy metabolism in rat hippocampus. In the present study we initially investigated the influence of pretreatment with alpha-tocopherol and ascorbic acid on the effects produced by arginine on hippocampus energy metabolism. We also tested the effect of acute administration of arginine on various parameters of energy metabolism, namely glucose uptake, lactate release and on the activities of succinate dehydrogenase, complex II and cytochrome c oxidase in rat cerebellum, as well as the influence of pretreatment with alpha-tocopherol and ascorbic acid on the effects elicited by arginine on this structure. 2. Sixty-day-old female Wistar rats were treated with a single i.p. injection of saline (control) or arginine (0.8 g/kg) and were killed 1 h later. In another set of experiments, the animals were pretreated for 1 week with daily i.p. administration of saline (control) or alpha-tocopherol (40 mg/kg) and ascorbic acid (100 mg/kg). Twelve hours after the last injection of the antioxidants the rats received one i.p. injection of arginine (0.8 g/kg) or saline and were killed 1 h later. 3. Results showed that arginine administration significantly increased lactate release and diminished glucose uptake and the activities of succinate dehydrogenase and complex II in rat cerebellum. In contrast, complex IV (cytochrome c oxidase) activity was not changed by this amino acid. Furthermore, pretreatment with alpha-tocopherol and ascorbic acid prevented the impairment of energy metabolism caused by hyperargininemia in cerebellum and hippocampus of rats.


Asunto(s)
Antioxidantes/farmacología , Ácido Ascórbico/farmacología , Metabolismo Energético/efectos de los fármacos , Hipocampo , Hiperargininemia/metabolismo , alfa-Tocoferol/farmacología , Animales , Antioxidantes/administración & dosificación , Arginina/administración & dosificación , Arginina/farmacología , Ácido Ascórbico/administración & dosificación , Complejo II de Transporte de Electrones/metabolismo , Complejo IV de Transporte de Electrones/metabolismo , Femenino , Glucosa/metabolismo , Hipocampo/efectos de los fármacos , Hipocampo/metabolismo , Humanos , Ácido Láctico/metabolismo , Ratas , Ratas Wistar , Succinato Deshidrogenasa/metabolismo , alfa-Tocoferol/administración & dosificación
20.
Metab Brain Dis ; 20(2): 97-103, 2005 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15938128

RESUMEN

In the present study we investigate the effect of homocysteine (Hcy) administration, the main metabolite accumulating in homocystinuria, on butyrylcholinesterase (BuChE) activity in serum of rats. For the acute treatment, 29-day-old Wistar rats received one subcutaneous injection of Hcy (0.6 micromol/g) or saline (control) and were killed 1 h later. For the chronic treatment, Hcy was administered subcutaneously to rats from the 6th to the 28th day of life. Control rats received saline. The rats were killed 12 h after the last injection. In another set of experiments, rats were pretreated for one week with vitamins E and C or saline and 12 h after the last injection received one single injection of Hcy or saline, being killed 1 h later. Serum was used to determine BuChE activity. Our results showed that acute and chronic administration of Hcy significantly decreased BuChE activity. Furthermore, vitamins E and C per se did not alter BuChE activity, but prevented the reduction of this enzyme activity caused by acute administration of Hcy. The data suggest that the inhibitory effect of Hcy on BuChE activity is probably mediated by free radicals, since vitamins E and C administration prevented such effect.


Asunto(s)
Butirilcolinesterasa/sangre , Regulación hacia Abajo/efectos de los fármacos , Homocistinuria/enzimología , Hiperhomocisteinemia/enzimología , Animales , Antioxidantes/metabolismo , Antioxidantes/farmacología , Arteriosclerosis/enzimología , Arteriosclerosis/fisiopatología , Ácido Ascórbico/metabolismo , Ácido Ascórbico/farmacología , Modelos Animales de Enfermedad , Regulación hacia Abajo/fisiología , Activación Enzimática/efectos de los fármacos , Activación Enzimática/fisiología , Radicales Libres/antagonistas & inhibidores , Radicales Libres/metabolismo , Homocisteína/metabolismo , Homocisteína/farmacología , Homocistinuria/sangre , Homocistinuria/tratamiento farmacológico , Hiperhomocisteinemia/sangre , Hiperhomocisteinemia/tratamiento farmacológico , Metabolismo de los Lípidos , Estrés Oxidativo/efectos de los fármacos , Estrés Oxidativo/fisiología , Ratas , Ratas Wistar , Vitamina E/metabolismo , Vitamina E/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA